Literature DB >> 29922623

Malnutrition and Opportunistic Infections among People Living with HIV Receiving Anti-retroviral Therapy in Aceh, Indonesia.

Cut Llf Putri1, Masra L Siregar2,3, Harapan Harapan1,4,5, Husnah Husnah6.   

Abstract

Entities:  

Year:  2018        PMID: 29922623      PMCID: PMC6005975     

Source DB:  PubMed          Journal:  Iran J Public Health        ISSN: 2251-6085            Impact factor:   1.429


× No keyword cloud information.

Dear Editor-in-Chief

In 2015, the number of people living with HIV (PLHIV) receiving antiretroviral therapy (ART) reaching 17.0 million people (1). Globally, scale-up of ART has surpassed expectations, but ART is not without adverse effects. It causes nausea, vomiting, loss of appetite, diarrhea, and therefore affects nutritional status. The prevalence of malnutrition among receiving ART was substantially high (2). In addition, the incidence of HIV-associated opportunistic infections (OIs) is still a major problem in the era of highly active ART (3). Although the prevalence of PLHIV in Aceh is significantly increased (4) and social aspects of PLHIV have been reported (5, 6), study regarding clinical and nutritional aspects of PLHIV from this area is unavailable. Therefore, this study was conducted to assess the prevalence of malnutrition and type of OI among PLHIV in Aceh, Indonesia. This cross-sectional study was conducted at Voluntary, Counseling, and Testing (VCT) clinic of Dr. Zainoel Abidin Hospital, Banda Aceh, Indonesia from 1 Jul to 30 Nov 2016. Nutritional information was collected using Mini Nutritional Assessment-directed interview and anthropometric measurements of body composition. Basic demographics and clinical data, and information about ART (the length and regimens) and data on OI were retrieved from patient records. The association of ART duration and nutritional status was assessed using Spearman correlation. This study was approved by the Ethics Committee of School of Medicine, Syiah Kuala University, Banda Aceh, Indonesia. Forty PLHIVs were included and analyzed. The characteristics of the participants are presented in Table 1.
Table 1:

Characteristics, type opportunistic infection and prevalence of malnutrition among the people living with HIV in Aceh (n=40)

CharacteristicFrequency (%)
Gender
  Male25 (62.5)
  Female15 (37.5)
Age(yr)
  18–256 (15.0)
  26–3522 (55.)
  36–459 (22.5)
  46–553 (7.5)
Duration of HIV infection
  < 1 tahun13 (32.5)
  1–2 tahun13 (32.5)
  3–4 tahun9 (22.5)
  ≥5 tahun5 (12.5)
HIV transmission route
  Heterosexual26 (65.0)
  Homosexual11 (27.5)
  Bisexual1 (2.5)
  Healthcare-related1 (2.5)
  Injection drug1 (2.5)
Antiretroviral therapy regimens
  AZT + 3 TC + NVP27 (67.5)
  AZT + 3 TC + EFV4 (10)
  TDF + 3 TC + NVP7 (17.5)
  TDF + 3 TC + EFV2 (5.0)
Duration of ART
  Less than 3 months9 (22.5)
  ≥3 months31 (77.5)
Opportunistic infection(s)
  Pulmonary tuberculosis7 (17.5)
  Extrapulmonary tuberculosis4 (10.0)
  Chronic diarrhea9 (22.5)
  Oral candidiasis4 (10.0)
  Seborrheic dermatitis1 (2.5)
  Pulmonary tuberculosis + oral candidiasis3 (7.5)
  Seborrheic Dermatitis + oral candidiasis1 (2.5)
  Chronic diarrhea + oral candidiasis5 (12.5)
  Chronic diarrhea + Toxoplasmosis1 (2.5)
  Pulmonary tuberculosis + chronic diarrhea + oral candidiasis3 (7.5)
  Chronic diarrhea + oral candidiasis + meningitis1 (2.5)
  Oral candidiasis + herpes + seborrheic dermatitis1 (2.5)
Nutritional status*
  Normal nutritional status10 (25.5)
  At risk of malnutrition23 (57.5)
  Malnourished7 (17.5)

AZT: Zidovudine, EFV: Efavirenz, NVP: Nevirapine, 3TC: Lamivudine or epivir, TDF: Tenofovir disoproxil fumarate

Based on Mini Nutritional Assessment (MNA)

Characteristics, type opportunistic infection and prevalence of malnutrition among the people living with HIV in Aceh (n=40) AZT: Zidovudine, EFV: Efavirenz, NVP: Nevirapine, 3TC: Lamivudine or epivir, TDF: Tenofovir disoproxil fumarate Based on Mini Nutritional Assessment (MNA) Majority of the participants (62.5%) was male and most of them were infected via heterosexual transmission (65.0%). All of the participants had current or past history of OI, of which chronic diarrhea was the most predominant (22.5%) followed by pulmonary tuberculosis (17.5). Only approximately a quarter of the participants were had normal nutritional status while 17.7% and 57.5 of them were malnourished and at risk of malnutrition, respectively. Spearman correlation test revealed a substantial correlation between ART duration and malnutrition (r=0.397, P=0.011). This study suggests that there is correlation between the lengths of ART and the prevalence of malnutrition among PLHIV receiving ART in Aceh. Therefore, regular screening and evaluation of nutritional status are important. Education and training to improve dietary are important to be conducted because adequate and diversified nutrition is necessary to manage OIs, maintain the immune system, optimize response to medical treatment, and support optimal quality of life in PLHIV (7). A standardized nutritional supplement along with ART could be implemented. Nutritional supplementation with ART was improved not only immune response and weight gain but also drug adherence and physical activity among PLHIV in South Africa (8). Besides, strengthening household food security status of PLHIV and regular checkup of simple indication of OIs among PLHIV in general and those taking ART, in particular, is recommended.
  2 in total

Review 1.  Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy.

Authors:  J E Kaplan; D Hanson; M S Dworkin; T Frederick; J Bertolli; M L Lindegren; S Holmberg; J L Jones
Journal:  Clin Infect Dis       Date:  2000-04       Impact factor: 9.079

2.  Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy.

Authors:  Denise Evans; Lynne McNamara; Mhairi Maskew; Katerina Selibas; Desiree van Amsterdam; Nicola Baines; Tracey Webster; Ian Sanne
Journal:  Nutr J       Date:  2013-08-06       Impact factor: 3.271

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.